Four brand products, one price
The catalogue lists two compounded products and four brand-name ones. Each brand entry has its own one-line description — one names a pre-filled weekly pen, another describes long-term weight management — and each carries the same starting monthly figure. All four. Two manufacturers, two molecules, four presentations, one number.
That is worth stating plainly: a single rate covering four different products is a seller-set price, not a pass-through of anything, and nothing on the page says what a plan at that rate contains, how long it runs, or whether the figure covers the drug alone.
Fifty of the ninety-five sellers here offer a brand route of some kind, and very few of them publish a figure. This one does, so the disclosure counts. The uniformity is what to read carefully.
Three promotional rates, three pages, one reading
On the compounded semaglutide product page, a banner offers a three-month supply at a stated total with a code and quotes a resulting per-month figure. On the Mounjaro page, a different banner offers compounded tirzepatide at a different per-month figure with a different code. On the Ozempic page, a third banner offers compounded semaglutide at a third figure, with the same code as the second. The catalogue carries a fourth banner offering a percentage off with that code.
None of those four matches the two plan rates printed on the product page itself, which are a one-month rate and a three-month rate with its total.
We read all of them in one session, on pages whose requested path equalled their effective path, with a nonsense-path control on the same host returning a not-found response in the same run. This is not a stale cache. It is what the site says about itself right now, in four places, and it says four different things.
Our record stores the plan rates, because those are the figures the seller prints as prices rather than as offers. The promotional figures are recorded in this row's own notes as what they are: codes, on banners, none agreeing with another.
The compounded plan rates are the readable part
Underneath the banners the product page does something sensible. It offers a one-month plan and a three-month plan, prints the per-month figure for each, prints the total for the three-month one, and states the discount as a percentage. Divide the total by three and it gives the per-month figure exactly. Take the stated percentage off the one-month rate and you land within a rounding of the same place.
That is internally consistent, which makes the banners above it stranger rather than less strange. The seller can price coherently; on three of its pages it chooses not to.
The tirzepatide page carries a starting figure and the catalogue carries its three-month total. Both product pages also state that the card is only charged if a licensed provider approves you, which is a real disclosure about when money moves.
What the documents say, and what is missing
The operating company is named in the first sentence of the privacy policy and again in the Terms, which is clean. No pharmacy is named. No individual clinician is named. Sixty-nine of the ninety-five sellers here name no compounding pharmacy and fifty-one name nobody who prescribes.
On membership the site says nothing. We ran a word-bounded census across five documents — both product pages, the catalogue, a privacy policy of nearly thirty thousand characters and Terms of nearly sixty thousand — and the word appears exactly once, inside a sentence saying the services are not a substitute for health insurance such as membership in a managed-care plan. That is an insurance disclaimer, not a fee statement. Twenty-five of the ninety-five sellers here say nothing either way.
On coverage the Terms make the reader do the asserting: you confirm that you live in the United States and in a state or territory where the services are available. No list follows. Fifty-eight of the ninety-five sellers here publish no service area at all.
The telehealth policy linked from the footer of every page returns a not-found response. A link in a footer is not a document.
Corsica Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $249/moThe one-month list rate from the product page plan selector: "1 Month Plan ($249 per Month)". The catalogue heads the same product "Semaglutide / Affordable compounded Semaglutide for steady, ongoing weight loss. / Starting from / $149.00 /mo", so the catalogue advertises the three-month rate and the product page the monthly one. | September 2026source |
| Semaglutide (compounded) | $149/moThe three-month plan with its total: "3 Month Plan ($149 per Month - 40% off) / $447.00". $447 ÷ 3 = $149 exactly, and 40% off the $249 monthly rate is $149.40, so the discount claim is very nearly the arithmetic. | September 2026source |
| Tirzepatide (compounded) | $249/mo"Tirzepatide Injection / Plans Starting at $249/month" on the product page, and in the catalogue "Tirzepatide / Dual-action compounded Tirzepatide for enhanced weight loss. / Starting from / $249.00 /mo". The three-month total for this product appears in the catalogue drawer as $747.00. | September 2026source |
| Semaglutide (brand) | $1,499/moFrom the seller catalogue: "Ozempic / Brand-name Semaglutide in a convenient, pre-filled weekly pen. / Starting from / $1,499.00 /mo" and "Wegovy / Brand-name Semaglutide designed for long-term weight loss. / Starting from / $1,499.00 /mo". ⚠ Identical to the tirzepatide brand figure on the same page. | September 2026source |
| Tirzepatide (brand) | $1,499/moFrom the same catalogue: "Zepbound / Brand-name Tirzepatide designed for chronic weight management. / Starting from / $1,499.00 /mo" and "Mounjaro / Brand-name Tirzepatide in a pre-filled pen for weight management. / Starting from / $1,499.00 /mo". | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 95 providers reviewed here are paid partners today; the other 91 are not. See how this works.
See Corsica Health's current price →Good fit if
- Readers who want a brand-name cash figure visible without an intake, on a plain catalogue page.
- Buyers who want the prepaid total printed beside the three-month per-month figure, and who will check that it divides.
- People who want compounded and branded lanes separated in the seller's own navigation.
- Anyone who wants to be told the card is only charged once a provider approves them.
Look elsewhere if
- Anyone who needs one price to mean one thing. Three promotional rates for compounded product ride three of this site's pages in a single reading, and none of them matches the plan rates.
- Readers reading the brand figure as a product price. One identical number covers four products from two manufacturers, with no plan length or contents stated.
- Buyers who want the membership question answered. Across five documents the word appears once, in an insurance disclaimer.
- Anyone who wants the compounding pharmacy or a prescribing clinician named.
- Readers who expect the linked telehealth policy to exist. It returns a not-found response.
How this review was verified
- Re-read the compounded semaglutide product page, the tirzepatide page, the catalogue, both brand product pages, the privacy policy and the Terms of Service on 6 September 2026 rather than carrying any figure across from the research file that nominated this seller.
- Recorded all four promotional banner figures with the page each appeared on, rather than choosing one, and kept them out of the price rows because a code on a banner is not a published plan rate.
- Checked the arithmetic on the compounded plans: the three-month total divided by three gives the printed per-month figure exactly, and the stated percentage off the one-month rate lands within a rounding of it.
- Read the four brand entries from the catalogue as rendered text, each with its own description and its own starting figure, and noted that all four figures are identical.
- Ran a word-bounded census for membership across five documents totalling well over eighty thousand characters of extracted text, and found one occurrence, inside an insurance disclaimer.
- Requested the telehealth policy linked from every page footer and recorded the result: a not-found response.
- Printed the status, byte size and effective URL of every fetch, compared the effective path to the requested one, and ran a nonsense path against this host in the same run. It returned a not-found response — with a body of more than two hundred thousand bytes, which is why nothing here was judged by size.
- Screened the operating entity and the brand name against FDA's live warning-letter record with a positive control and a nonsense-string negative control in the same run. Neither returned a letter; untitled letters are published separately and were not searched.